Thiopurine S-methyltransferase activity in Nigerians: phenotypes and activity reference values

por Adehin, Ayorinde, Bolaji, Oluseye O.
Publicado 2018

Validation and Clinical Application of a Liquid Chromatography-Ultraviolet Detection Method to Quantify Dolutegravir in Dried Blood Spots

por Akinloye, Abdulafeez, Eniayewu, Oluwasegun, Adeagbo, Babatunde, Bolaji, Oluseye, Olagunju, Adeniyi
Publicado 2022

Vitamin A deficiency among under-five Nigerian children with diarrhoea

por Abolurin, Olufunmilola O, Adegbola, Adebanjo J, Oyelami, Oyeku A, Adegoke, Samuel A, Bolaji, Oluseye O
Publicado 2018

African Pharmacogenomics Consortium: Consolidating pharmacogenomics knowledge, capacity development and translation in Africa: Consolidating pharmacogenomics knowledge, capacity de...

por Dandara, Collet, Masimirembwa, Collen, Haffani, Yosr Z., Ogutu, Bernhards, Mabuka, Jenniffer, Aklillu, Eleni, Bolaji, Oluseye
Publicado 2019

Breast Cancer and Tamoxifen: A Nigerian Perspective to Effective Personalised Therapy

por Adehin, Ayorinde, Kennedy, Martin Alexander, Soyinka, Julius Olugbenga, Alatise, Olusegun Isaac, Olasehinde, Olalekan, Bolaji, Oluseye Oladotun
Publicado 2020

Using mechanistic physiologically-based pharmacokinetic models to assess prenatal drug exposure: Thalidomide versus efavirenz as case studies

por Atoyebi, Shakir Adeyinka, Rajoli, Rajith K.R., Adejuyigbe, Ebunoluwa, Owen, Andrew, Bolaji, Oluseye, Siccardi, Marco, Olagunju, Adeniyi
Publicado 2019

Pharmacokinetic Parameters of Quinine in Healthy Subjects and in Patients with Uncomplicated Malaria in Nigeria: Analysis of Data using a Population Approach

por Adehin, Ayorinde, Igbinoba, Sharon I., Soyinka, Julius O., Onyeji, Cyprian O., Babalola, Chinedum P., Bolaji, Oluseye O.
Publicado 2019

Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using liquid chromatography tandem mass spectrometry

por Olagunju, Adeniyi, Nwogu, Jacinta, Eniayewu, Oluwasegun, Atoyebi, Shakir, Amara, Alieu, Kpamor, John, Bolaji, Oluseye, Adejuyigbe, Ebunoluwa, Owen, Andrew, Khoo, Saye
Publicado 2022

Controlled Covalent Conjugation of a Tuberculosis Subunit Antigen (ID93) to Liposome Improved In Vitro Th1-Type Cytokine Recall Responses in Human Whole Blood

por Adeagbo, Babatunde Ayodeji, Akinlalu, Akintunde Oluseto, Phan, Tony, Guderian, Jeff, Boukes, Gerhardt, Willenburg, Elize, Fenner, Caryn, Bolaji, Oluseye Oladotun, Fox, Christopher B.
Publicado 2020

A snapshot of the prevalence of dihydropteroate synthase-431V mutation and other sulfadoxine-pyrimethamine resistance markers in Plasmodium falciparum isolates in Nigeria

por Adegbola, Adebanjo J., Ijarotimi, Omotade A., Ubom, Akaninyene E., Adesoji, Bukola A., Babalola, Olajide E., Hocke, Emma F., Hansson, Helle, Mousa, Andria, Bolaji, Oluseye O., Alifrangis, Michael, Roper, Cally
Publicado 2023

Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised...

por Olagunju, Adeniyi, Fowotade, Adeola, Olagunoye, Ajibola, Ojo, Temitope Olumuyiwa, Adefuye, Bolanle Olufunlola, Fagbamigbe, Adeniyi Francis, Adebiyi, Akindele Olupelumi, Olagunju, Omobolanle Ibitayo, Ladipo, Olabode Taiwo, Akinloye, Abdulafeez, Adeagbo, Babatunde Ayodeji, Onayade, Adedeji, Bolaji, Oluseye Oladotun, Happi, Christian, Rannard, Steve, Owen, Andrew
Publicado 2021

A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19

por Fowotade, Adeola, Bamidele, Folasade, Egbetola, Boluwatife, Fagbamigbe, Adeniyi F., Adeagbo, Babatunde A., Adefuye, Bolanle O., Olagunoye, Ajibola, Ojo, Temitope O., Adebiyi, Akindele O., Olagunju, Omobolanle I., Ladipo, Olabode T., Akinloye, Abdulafeez, Onayade, Adedeji, Bolaji, Oluseye O., Rannard, Steve, Happi, Christian, Owen, Andrew, Olagunju, Adeniyi
Publicado 2022